A single administration of a novel, nasally delivered influenza vaccine elicited immune responses in ferrets that were more than 20 times higher than those generated by two injections of the currently approved vaccines, according to a study by NanoBio Corporation.
Agilent Technologies Inc. and BioTrove today announced that they have signed a non-exclusive value-added reseller agreement to enable BioTrove to provide an end-to-end solution for mass spectrometry-based drug discovery.
The chips are based on UMC's independently developed low-leakage (LL) process technology. UMC utilized advanced double-patterning immersion lithography and strained silicon technology to produce the chips, which feature very small six-transistor SRAM cell sizes of approximately 0.122 square micrometers.
As part of its commitment to promote basic research in the life sciences, Applied Biosystems Inc. today announced the creation of a grant program for genomic, epigenomic and transcriptome studies. The $10K Genome Grant Program is based on the concept of sequencing an entire genome for $10,000.
Ener1, Inc., a leading manufacturer of lithium-ion batteries for the automotive industry, announced today the closing of its acquisition of an 83% interest in Enertech International, one of South Korea's largest lithium-ion cell producers.
Seo-Kwang Co.,Ltd, a manufacturer of various well-being products based on its Silver Nano Colloid technology in South Korea, announced today that they will launch their new Nano Silver products in the global market, beginning with the distribution in China, Singapore, Southeast Asia, and Middle East.
Thermo Fisher Scientific Inc., the world leader in serving science, has introduced new Thermo Scientific PocketTip D.A.R.T.s tips, enabling nanoliter volume dispensing on Thermo Scientific Matrix automated systems.
New experimental work using the Sysmex FPIA-3000 and Spraytec systems from Malvern Instruments, highlights the complementary nature of particle characterization by image analysis and laser diffraction respectively, when applied to the development of pharmaceutical nebulizers.
BioSolar, Inc. announced today that it has filed a patent application to protect the novel inventions and processes behind its proprietary bio-based backsheet, a protective covering for the back of photovoltaic solar cells traditionally made from expensive petroleum-based film.
Nanogen, Inc., developer of molecular-biology and rapid diagnostic products, announced today that Celera Corporation has extended its license agreement of Nanogen?s patent portfolio in molecular biology to develop additional diagnostic products.
At the ISPE Annual Meeting, pharmaceutical manufacturing industry professionals from around the world will gather to share experiences and gain insights affecting industry change. The upcoming annual meeting will be held from October 26-29, 2008, in Boca Raton, FL.